invivodata Recognized as One of Pittsburgh’s Fastest Growing Private Companies

     Pittsburgh Business Times Names invivodata to 2008 Pittsburgh 100



    PITTSBURGH, Aug. 25 /
EMWNews
/ -- invivodata inc., the industry

leader in electronic patient reported outcomes (ePRO) solutions and

services for global clinical research, today announced that the Pittsburgh

Business Times has recognized the company in the "2008 Pittsburgh 100"

annual ranking of the fastest-growing, privately-held companies in Western

Pennsylvania.



    "We see the Pittsburgh 100 as one of the most important lists we

publish," said Alan Robertson, publisher of the Pittsburgh Business Times.

"The companies on this list represent many industries and many geographic

locations around the region. The Pittsburgh 100 companies also represent

all different sizes of companies, from small firms to multi-billion dollar

operations. We see the Pittsburgh 100 as proof that the region remains a

vibrant, growth-oriented business environment."



    Rankings on the list were based on the rate of growth from 2005 through

2007. Honored at an awards program at the Duquesne Club in downtown

Pittsburgh on August 21, invivodata was ranked the 10th fastest-growing

technology company and #43 overall on the list of 100, based on revenue

growth.



    "We're very proud to be included in the Pittsburgh 100," said Doug

Engfer, invivodata president and CEO. "We believe our inclusion in the list

is representative of the consistent results we are delivering to our new

and existing customers, and the growing demand for our ePRO solutions and

expertise."

    About invivodata inc.



    invivodata combines behavioral science, information technology, and

clinical research expertise to capture high quality clinical trial data

directly from patients. invivodata's electronic Patient Reported Outcomes

(ePRO) solutions, which are based on over 20 years of research, deliver

reliable patient self-reported data by driving patient compliance with the

protocol and eliminating recall biases that plague paper-based self-report

data. invivodata's solutions include comprehensive trial-support services

that facilitate the collection of ePRO data, and web-based access to study

data and operational reports that give researchers and sponsors visibility

into study progress and improve trial efficiencies. invivodata's solution

has been used in more than 200 trials and is the industry-leading ePRO

system in delivering primary efficacy data for FDA drug approvals.

invivodata inc. is a privately held company with global headquarters in

Pittsburgh, Pa., USA; its European headquarters is in London, England; and

its technology development center is in Scotts Valley, Calif., USA. For

more information visit http://www.invivodata.com/.






    For more information, contact:

    invivodata inc.

    Christine Tobin

    Corporate Communications Specialist

    (412) 390-3000, ext. 3502

    [email protected]